Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2002
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
Simone Cowan, Theodora Hatziioannou, Tshaka Cunningham, et al.
Molecular Endocrinology (Baltimore, Md.)
|
October 13, 2007
Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy
Shashi Shrivastav, Tomoshige Kino, Tshaka Cunningham, et al.
Nature Medicine
|
July 17, 2012
Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
Qing Zhu, James Talton, Guofeng Zhang, et al.
Cell Reports Methods
|
March 1, 2022
Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs
Brian Hetrick, Linda D Chilin, Sijia He, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2002
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
Simone Cowan, Theodora Hatziioannou, Tshaka Cunningham, et al.
Molecular Endocrinology (Baltimore, Md.)
|
October 13, 2007
Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy
Shashi Shrivastav, Tomoshige Kino, Tshaka Cunningham, et al.
Nature Medicine
|
July 17, 2012
Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
Qing Zhu, James Talton, Guofeng Zhang, et al.
Cell Reports Methods
|
March 1, 2022
Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs
Brian Hetrick, Linda D Chilin, Sijia He, et al.
Page
of 1